# Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers

> **NCT06141889** · PHASE1 · COMPLETED · sponsor: **BioAge Labs, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** Azelaprag

## Key facts

- **NCT ID:** NCT06141889
- **Lead sponsor:** BioAge Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-17
- **Primary completion:** 2024-01-26
- **Final completion:** 2024-02-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06141889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06141889, "Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06141889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*